As current diagnostic assays for leprosy are antibody-based and only facilitate the diagnosis of MB cases33, 34, 35, inclusion of the host immune markers CCL4 and IP-10 in the profile shows promise for diagnosis of PB patients and indicates the importance of measuring cellular markers simultaneously with humoral markers. The gene discussed is CCL4; the disease is leprosy.